Richard D Francis sold $14.3M of Teva Pharmaceutical Industries Limited (TEVA)

Executed Mar 3, disclosed Mar 5, 2 days later.

Value, as filed

$14.3M

442,935 sh across 2 lots

Executed

Mar 3

the trade date, as filed

Disclosed

Mar 5

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Richard D Francis President and CEO profile →

Richard D Francis (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $15.3M of TEVA (447,778 sh across 2 lots, as filed), executed Feb 15.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Richard D Francis in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $211K
6,153 sh × $34.35
Exec Jun 5
Filed Jun 8 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $634K
20,025 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $759K
23,393 sh × $32.46
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $15.3M
447,778 sh across 2 lots
Exec Feb 15
Filed Feb 18 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $375K
23,773 sh across 2 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $503K
31,342 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $1.3M
75,506 sh × $16.95
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET